Certainly nice, but in my mind, the "$1,000/share"

Certainly nice, but in my mind, the "$1,000/share" statement undermines credibility, no matter how true (in years) it may be. Sounds like hyperbole and trying to get on the "kill the shorts train" in a way that isn't credible. But that's just my opinion, of course. I'd usually rather be more conservative in a way that people can relate to instead of using the pie in the sky mentality, especially for an OTC biotech with no revenue yet.